CONMED Comprehensive Income 2010-2024 | CNMD

CONMED comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
CONMED Annual Comprehensive Income
(Millions of US $)
2023 $-50
2022 $-58
2021 $-54
2020 $-64
2019 $-59
2018 $-56
2017 $-49
2016 $-59
2015 $-54
2014 $-40
2013 $-18
2012 $-28
2011 $-26
2010 $-16
2009 $-12
CONMED Quarterly Comprehensive Income
(Millions of US $)
2024-06-30 $-54
2024-03-31 $-50
2023-12-31 $-50
2023-09-30 $-54
2023-06-30 $-53
2023-03-31 $-55
2022-12-31 $-58
2022-09-30 $-60
2022-06-30 $-57
2022-03-31 $-53
2021-12-31 $-54
2021-09-30 $-60
2021-06-30 $-58
2021-03-31 $-63
2020-12-31 $-64
2020-09-30 $-62
2020-06-30 $-64
2020-03-31 $-66
2019-12-31 $-59
2019-09-30 $-58
2019-06-30 $-56
2019-03-31 $-56
2018-12-31 $-56
2018-09-30 $-46
2018-06-30 $-48
2018-03-31 $-46
2017-12-31 $-49
2017-09-30 $-48
2017-06-30 $-51
2017-03-31 $-55
2016-12-31 $-59
2016-09-30 $-52
2016-06-30 $-52
2016-03-31 $-51
2015-12-31 $-54
2015-09-30 $-54
2015-06-30 $-49
2015-03-31 $-50
2014-12-31 $-40
2014-09-30 $-21
2014-06-30 $-15
2014-03-31 $-17
2013-12-31 $-18
2013-09-30 $-27
2013-06-30 $-29
2013-03-31 $-27
2012-12-31 $-28
2012-09-30 $-27
2012-06-30 $-28
2012-03-31 $-25
2011-12-31 $-26
2011-09-30 $-12
2011-06-30 $-11
2011-03-31 $-13
2010-12-31 $-16
2010-09-30 $-13
2010-06-30 $-18
2010-03-31 $-13
2009-12-31 $-12
2009-09-30 $-11
2009-06-30 $-15
2009-03-31 $-22
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.343B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.939B 18.14
McKesson (MCK) United States $66.345B 18.25
Cardinal Health (CAH) United States $26.957B 14.91
West Pharmaceutical Services (WST) United States $22.428B 43.73
Cooper (COO) United States $22.013B 31.33
Labcorp (LH) United States $19.078B 15.89
Align Technology (ALGN) United States $18.899B 36.51
Henry Schein (HSIC) United States $9.181B 16.81
Merit Medical Systems (MMSI) United States $5.746B 30.37
DENTSPLY SIRONA (XRAY) United States $5.414B 14.52
Patterson (PDCO) United States $1.936B 10.21
STAAR Surgical (STAA) United States $1.544B 69.76
Lifevantage (LFVN) United States $0.127B 17.48
Pro-Dex (PDEX) United States $0.086B 41.13